期刊文献+

依那普利联合卡维地洛治疗老年慢性心衰的临床观察 被引量:8

暂未订购
导出
摘要 目的:讨论老年慢性心衰的治疗中,依那普利联合卡维地洛的疗效及药物的安全性。方法:老年慢性心衰患者74例,随机分为治疗组36例,对照组38例。对照组应用心力衰竭常规治疗方案(包含依那普利)治疗1年,治疗组以心力衰竭常规治疗方案(包含依那普利)联合应用卡维地洛治疗1年。结果:治疗组心功能改善,左心室舒张末径减小、射血分数增加较大,与对照组比较差异有统计学意义(P<0.05)。结论:依那普利联合卡维地洛治疗老年慢性心力衰竭安全、有效。
出处 《内蒙古医学杂志》 2011年第1期48-49,共2页 Inner Mongolia Medical Journal
  • 相关文献

参考文献9

二级参考文献20

  • 1付荣,姜东炬.心力衰竭的现代治疗[J].临床荟萃,2002,17(24):1477-1479. 被引量:2
  • 2高凯,王士斐,陈丽萍,刘健英.老年心力衰竭的临床特点[J].中华心血管病杂志,1995,23(5):377-379. 被引量:48
  • 3Sanderson JE, Chan SK, Yip G,et al. Beta -blockade in heart failure:a comparison of carvedilol with metoprolol [ J ]. J Am Coll Cardiol, 1999,34 (5) :1522 - 1528.
  • 4The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. US Carvedilol Heart Failure Study Group [ J ]. N Engl J Med,1996,334(21 ) :1349 - 1355.
  • 5CIBIS Ⅱ INVESTIGATIONS and committees . The Cardiac Insufficiency Bisoprolol Study Ⅱ(CIBIS - Ⅱ) :A randomized trial[ J]. Lancet, 1999, 353(9146) :9 -13.
  • 6郭冀珍.有应用前景的新一代α、β受体阻滞剂[N].中国医学论坛报,2009-09-17(C9).
  • 7Dargie HJ. Effect of carvedilol on outcome after myocardial infarction in patients with left - ventricular dysfunction : the CAPRICORN randomised trial[ J]. Lancet, 2001,357 (9266) : 1385 - 1390.
  • 8Kjekshus J. Beta - blocker treatment of chronic systolic heart failure improves prognosis even in patients meeting one or more exclusion criteria of the MERIT - HF study [J ]. Eur Heart J,2005,26 ( 24 ) ,2689 - 2690.
  • 9[1]Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.The SOLVD Investigators[J].N Engl J Med,1991,325:293-302
  • 10[1]Cleland JGF,McGowan J,Clark A.The evidence for βblockers in heart failure.BMJ,1999,318:824 - 825

共引文献19

同被引文献73

  • 1陈灏珠,樊冰.解读美国心脏病学院及美国心脏学会关于成人慢性心力衰竭评估和治疗指南[J].中华心血管病杂志,2004,32(8):673-675. 被引量:43
  • 2王志明,颜永进,张跃明.缬沙坦治疗慢性心力衰竭疗效观察[J].中国交通医学杂志,2004,18(6):664-665. 被引量:5
  • 3李跃,刘亭威.慢性心力衰竭的药物治疗和进展[J].现代医药卫生,2006,22(15):2319-2320. 被引量:6
  • 4Poole-wilson PA,SwedbergK,Cleland JG,et al. Comparison of caredilol and metoprolol on clinical outcomes in patients with chronic heart failure in the carvedilolar metoprolol European trial (COMET):randomised controlled trial[J]. Lancet, 2006,362 : 7-13.
  • 5中华医学会心血管病学分会,中华心血管病杂志编辑委员会.慢性心力衰竭诊断治疗指南[J].中华心血管病杂志,2007,35:1076-1095.
  • 6罗慧敏,苟娟.依那普利联合卡维地洛治疗治疗老年慢性心力衰竭的临床效果及安全性[J].医药前沿,2013(13):222-223.
  • 7Alehagen U, Dahlstr~m U, Rehfeld JF, et al. Association of copeptin and N-terminal proBNP concentration with risk of cardiovascular death in older patients with symptoms of heart failure [J]. JAMA, 2011, 305 (20):2088-2095.
  • 8Willenheimer R, van Veldhuisen DJ, Silke B, et al. Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril, as compared with the opposite sequence: results of the randomized cardiac insufficiency bisoprolol study (CIBIS) Ⅲ[J]. Circulation, 2005, 112 (16) : 2426 - 2435.
  • 9Bozkurt B, Bolos M, Deswal A, et al. New insights into mechanisms of action of carvedilol treatment in chronic heart failure patients a matter of time for contractility [ J ]. J Card Fail, 2012, 18 (3): 183-193.
  • 10丁怀兰,赵毅.缬沙坦联合卡维地洛治疗老年慢性充血性心力衰竭临床观察[J].中国社区医师(医学专业),2009,11(10):21-22. 被引量:4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部